Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers

Acta Psychiatrica Scandinavica

Volumn 95, Issue 3, 1997, Pages 212-221

  Maes, M ^a,b,f   Smith, R ^c   Christophe, A ^d   Vandoolaeghe, E ^a   Van Gastel, A ^a   Neels, H ^e   Demedts, P ^e   Wauters, A ^e   Meltzer, H Y ^b  

^a Stuivenberg General Hospital   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

^c Sierra Pacific Seminars   (United States)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e Lab of Clin Chem and Toxicology   (Belgium)

^f Clinical Research Center for Mental Health of Antwerp   (Belgium)

Author keywords

Cholesterol; Depression; Immunology; Lipids; Suicide

Indexed keywords

ALBUMIN; CHOLESTEROL; LIPOPROTEIN; MARKER; ZINC;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IMMUNITY; INFLAMMATION; MALE; PRIORITY JOURNAL; SUICIDE ATTEMPT; T LYMPHOCYTE;

EID: 0030971159     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09622.x     Document Type: Article

References (47)

1. HORROBIN DF. Essential fatty acids, psychiatric disorders and neuropathies. In: HORROBIN DF, ed. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss, 1990: 305-320.
2. HIBBELN JR, SALEM N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995: 62: 1-9.
3. SMITH RS. The macrophage theory of depression. Med Hypoth 1991: 35: 298-306.
4. MAES M, DELANGHE J, MELTZER HY, D'HONDT P, COSYNS P. Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 1994: 90: 252-258.
5. MAES M, SMITH R, CHRISTOPHE A, COSYNS P, DESNYDER R, MELTZER HY. Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased c20:4ω6/c20:5ω3 ratio in cholesteryl esters and phospholipids. J Affect Dis 1996: 38: 35-46.
6. MORGAN RE, PALINKAS LA, BARRETT-CONNEL EL, WINGARD DL. Plasma cholesterol and depressive symptoms in older men. Lancet 1993: 341: 75-79.
7. GLUECK CJ, TIEGER M, KUNKEL R, HAMER T, TRACY T, SPEIRS J. Hypocholesterolemia and affective disorders. Am J Med Sci 1994: 308: 218-225.
8. MCCALLUM J, SIMONS L, SIMONS J, FRIEDLANDER Y. Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study. Aust NZ J Med 1994: 24: 561-564.
9. SWARTZ C. Albumin decrement in depression and cholesterol decrement in mania. J Affect Dis 1990: 19: 173-176.
10. WEIDNER G, CONNOR SL, HOLLIS JF, CONNOR WE. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study. Ann Intern Med 1992: 117: 820-823.
11. ADAMS PB, LAWSON S, SANIGORSKI A, SINCLAIR AJ. Arachidonic acid to eicosapentanoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996: 31 (Suppl.): S157-S161.
12. SUBBAIAH PV, BANERJI B, GREGG RE, BAGDADE JD. Molecular species of cholesteryl esters formed in abetalipoproteinemia: effect of apoprotein B-containing lipoproteins. J Lipid Res 1990: 21: 927-932.
13. LINSCHEER WG, VERGROESEN AJ. Lipids. In: SHILS ME, YOUNG VR, ed. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1988: 72-107.
14. SABINE JR. Cholesterol. New York: Marcel Dekker, 1977.
15. BERNSTAM VA. Genetic aspects in reverse cholesterol transport. In: Handbook of gene level diagnostics in clinical practice. Ann Arbor: CRC Press, 1992: 178-181.
16. MULDOON MF, MANUCK SB, MATHEWS KM. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br Med J 1990: 301: 309-314.
17. ENGELBERG H. Low serum cholesterol and suicide. Lancet 1992: 339: 727-729.
18. LINDBERG G, RASTAM L, GULLBERG B, EKLUND GA. Low serum cholesterol concentration and short-term mortality from injuries in men and women. Br Med J 1992: 305: 277-279.
19. GOLIER JA, MARZUK PM, LEON AC, WEINER C, TARDIFF K. Low serum cholesterol level and attempted suicide. Am J Psychiatry 1995: 152: 419-423.
20. SULLIVAN PF, JOYCE PR, BULIK CM, MULDER RT, OUKLEY-BROWNE M. Total cholesterol and suicidality in depression. Biol Psychiatry 1994: 36: 472-477.
21. MAES M, MELTZER HYM. The serotonin hypothesis of major depression. In: BLOOM F, KUPHER D, ed. Psychopharmacology, the fourth generation of progress. New York: Raven Press, 1995: 933-941.
22. SCHILDKRAUT JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965: 122: 509-522.
23. MAES M. Evidence for an immune response in major depression: a review and hypothesis. Progr Psychopharmacol Biol Psychiatry 1995: 19: 11-38.
24. MAES M, SMITH R, SCHARPÉ S. The monocyte T-lymphocyte hypothesis of major depression. Invited editorial. Psychoneuroendocrinology 1995: 20: 111-116.
25. MEYDANI SN, ENDRES S, WOODS MM et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991: 121: 547-555.
26. ENDRES S. Messengers and mediators: interactions among lipids, eicosanoids and cytokines. Am J Clin Nutr 1993: 57: 798-800.
27. GRUNFELD C, FEINGOLD KR. Tumor necrosis factor, interleukin, and interferon-induced changes in lipid metabolism as part of host defense. Proc Soc Exp Biol Med 1992: 200: 224-227.
28. MEMON RA, FEINGOLD KR, GRUNFELD C. Role of cytokines in lipid metabolism and cachexia. In: AGGARWAL BB, PURI RK, ed. Human cytokines: their role in disease and therapy. Oxford: Blackwell Science, 1995: 239-251.
29. ETTINGER WH, MILLER LD, ALBERS JJ, SMITH TK, PARKS JS. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: acyltransferase in cynomolgus monkeys. J Lipid Res 1990: 31: 1099-1107.
30. BOOTH-KEWLEY S, FRIEDMAN HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987: 101: 343-362.
31. Anonymous. Fish oil and the development of atherosclerosis. Nutr Rev 1987: 45: 90-92.
32. HEISS G, JOHNSON NJ, REILAND S, DAVIS CE, TYROLER JA. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study Summary. Circulation 1980: 62: 116-136.
33. CONNOR WE, CERQUERIA MT, CONNOR RW, WALLACE RB, MALINOW MR, CASDORPH HR. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. Am J Clin Nutr 1987: 31: 1131-1142.
34. Belgian Lipid Club. Diagnose en Behandeling van Hyperlipidemieen bij Volwassenen. Gids in Zakformaat. De Huisarts, 1994.
35. DURRINGTON PN. Lipids and their metabolism. In: HORROBIN PN, ed. Hyperlipidaemia, diagnosis and management. Cambridge: Butterworth-Heinemann, 1995: 4-24.
36. POLLOCK BG, PEREL JM, PARADIS CF, FASICZKA AL, REYNOLDS CF. Metabolic and physiologic consequences of nortriptyline treatment in the elderly. Psychopharmacol Bull 1994: 30: 145-150.
37. FARRELL PM. Vitamin E. In: SHILS ME, YOUNG VR, ed. Modern nutrition in health and disease. Philadelphia: Lea and Febiger, 1988: 340-354.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1987.
39. SPITZER RL, WILLIAMS JBW, GIBBON MSW, FIRST MB. Structured clinical interview according to DSM-III-R. Washington, DC: American Psychiatric Press, 1990.
40. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960: 23: 56-62.
41. THASE ME, RUSH AJ. Treatment-resistant depression. In: BLOOM FE, KUPFER DJ, ed. Psychopharmacology, the fourth generation of progress. New York: Raven Press, 1995: 1081-1098.
42. TIETZ NW. Clinical guide to laboratory tests. Philadelphia: W.B. Saunders Company, 1990.
43. CATIGNANI GL, BIERI JG, DRISKELL WJ et al. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983: 29: 708-712.
44. HAWTON K, COWEN P, OWENS D, BOND A, ELLIOTT M. Low serum cholesterol and suicide. Br J Psychiatry 1993: 162: 818-825.
45. HERON DS, SHINITZKY M, HERSHKOWITZ M, SAMUEL D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA 1980: 77: 7463-7467.
46. YOUNG DS. Effects of preanalytical variables on clinical laboratory tests. Hudson, OH: American Association for Clinical Chemistry Press, 1993.
47. CHRISTOPHE A, VERMEULEN A. Effects of weight loss on the fatty acid composition of serum lipids in obese women. Ann Nutr Metab 1992: 36: 336-342.